MustGrow Biologics CEO Corey Giasson Talks To Cantech Letter

Saskatoon-based MustGrow Biologics (MustGrow Biologics Stock Quote, Chart, Info, Analysts, Financials TSXV:MGRO) is bringing biotechnology and regenerative agriculture collectively to help farmers change synthetic chemical compounds and fertilizers, CEO Corey Giasson talked about in an Oct. 31 interview on the Cantech Letter YouTube channel.

Speaking with Ticker Take host Jon Erlichman on the 2025 Cantech Funding Conference in Toronto, Giasson talked about the company’s patented mustard-seed know-how is now transferring from evaluation to full enterprise manufacturing.

“MustGrow is an agricultural biotech agency,” Giasson talked about. “We’ve obtained a patented know-how spherical mustard that extracts compounds from mustard seed, reformulates them into biopesticides and biofertility merchandise to help change synthetic chemical compounds or fertilizers and help regenerative agriculture.”

He talked about the tactic attracts on nature’s private defences. “You eat it when you should have mustard, it’s the spice that you just get contained in the mustard, and it just so happens that it’s very environment friendly at treating illnesses and pests that farmers should be concerned about,” he talked about. “It’s the pure defence mechanism of that plant.”

MUSTGROW BIOLOGICS CEO COREY GIASSON SITS DOWN WITH JON ERLICHMAN AT THE 2025 CANTECH INVESTMENT CONFERENCE

Giasson added that regulatory and consumer pressures are accelerating the shift in the direction of biologic alternate choices.

“We’re seeing very important progress,” he talked about. “We’ve seen pretty somewhat little bit of pesticides or chemical compounds being banned or restricted, and farmers nonetheless have to develop crops with a finite amount of arable land. That’s what we’re bringing to the desk, a pure biologic that works.”

MustGrow has moreover broadened its attain with the acquisition of NexusBioAg, a Canadian product sales and distribution enterprise centered on regenerative agriculture merchandise.

“So we’re a very built-in agriculture provider,” Giasson talked about.

He talked about the company has these days entered a model new part.

“I’m excited that we’ve turned the nook and we’re now in commercialization and product sales,” Giasson talked about. “We’ve carried out about $6.6-million of revenue throughout the first half of this 12 months, and we have to proceed to drive that amount by way of NexusBioAg in Canada and through TerraSante, our biofertility product registered within the USA.”

TerraSante is a wettable-powder soil additive derived from mustard seed, used to boost soil effectively being, water functionality, and plant effectivity. Giasson talked about early demand has exceeded expectations.

“We ran out of product this spring; it’s an important downside to have, nonetheless it’s a difficulty,” he talked about. “We’re now searching for to ramp up manufacturing so as that we are going to meet demand subsequent 12 months. The sphere trials have confirmed constructive outcomes, and we’re starting to see repeat product sales.”

-30-